Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer Phillip G. Rowse, MD, Dawn E. Jaroszewski, MD, Mathew Thomas, MD, Kristi Harold, MD, William S. Harmsen, MS, K. Robert Shen, MD The Annals of Thoracic Surgery Volume 104, Issue 4, Pages 1147-1152 (October 2017) DOI: 10.1016/j.athoracsur.2017.05.030 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Overall survival between men and women. The Annals of Thoracic Surgery 2017 104, 1147-1152DOI: (10.1016/j.athoracsur.2017.05.030) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Recurrence-free survival between men and women. The Annals of Thoracic Surgery 2017 104, 1147-1152DOI: (10.1016/j.athoracsur.2017.05.030) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Recurrence-free survival based on pathologic response to neoadjuvant chemoradiotherapy (nCRT). The Annals of Thoracic Surgery 2017 104, 1147-1152DOI: (10.1016/j.athoracsur.2017.05.030) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions